A study of risk factors in the development of diabetic foot: 1N campaign
DOI:
https://doi.org/10.47196/diab.v55i1.468Keywords:
diabetic foot, diabetic neuropathy, screening, diabetes mellitus, complications.Abstract
Introduction: foot examination is essential in patients with diabetes mellitus (DM). The correct evaluation of the foot in the patient who attends diabetes control is key to establish risk factors for the development of ulcers, detect injuries, take preventive measures, make an early referral and educate in foot care.
Objectives: in this study, the feet of people with DM were examined during the Diabetic Foot Awareness and Prevention Campaign on November 1, 2019 in order to assess the presence of symptoms and signs related to neuropathy, peripheral vascular disease, prevalence of the same and know the risk.
Materials and methods: 165 patients were analyzed in four centers: Sanatorio Güemes (Diabetes and Endocrinology Service), PREDIGMA (Preventive Medicine Center, Posadas, Misiones), Central Hospital of San Isidro, Nexo Medical Center (Junín City) and Hospital Municipal of General Viamonte (Province of Buenos Aires).
Results: it was found that 43.6% had some symptoms in the lower limbs and up to 57% had an alteration in the screening tests for diabetic neuropathy or peripheral arterial disease, with a higher prevalence the longer the evolution of DM.
The most frequent signs found in the physical examination were: dry skin (71.5%), nail dystrophy (60.6%) or alteration of the foot pad (52.1%). The most frequent comorbidities were: hypertension (74.5%) and dyslipidemia (73.3%). The median glycated hemoglobin was 7.40% (6.70-8.10), higher in people with a history of retinopathy (7.8%; p <0.01) and in patients who reported having cramps (7, 85 to 7.30; p = 0.03) or burning (8.0 vs 7.3; p <0.01).
The percentage of patients with high-risk foot due to antecedents, inspection or screening for neuropathy or vascular disease represented from 40% in those with DM of less than five years of evolution to 86% in those who were older than 20 years.
Conclusions: this high percentage of patients with foot at risk identified in this study suggests that, in addition to the correct physical examination, the attending physician requires the taking of behaviors, such as the indication of appropriate footwear or insoles, as well as a fluid referral to the orthotic technician, orthopedic surgeon, or physiatrist.
References
I. Boulton A. The diabetic foot: grand overview, epidemiology and pathogenesis. Diabetes Metab Res Rev 2008; 24:S3-S6.
II. Rodríguez-Bolaños RA, Reynales-Shigematsu LM, Giménez-Ruiz JA, et al. Costos directos de atención médica en pacientes con diabetes mellitus tipo 2: análisis de microcosteo. Rev Pan Salud Pub 2010; 28:412-420.
III. Hicks C, Selvin E. Epidemiology of peripheral neuropathy and lower extremity disease in diabetes. Curr Diab Rep 2019; 19(10):86
IV. Ruiz M. Diabetes mellitus. Cuarta edición. Ed AKADIA. 2011.
V. Pop-Busui R, Boulton A, Feldman E, et al. Diabetic neuropathy: a position statement by the American Diabetes Association. Diabetes Care 2017; 40(1):136-154.
VI. Hinchliffe R, Fortsythe R, Apelqvist J, et al. IWGDF guidelines on diagnosis, prognosis and management of peripheral arterial disease in patients with a foot ulcer and diabetes. Disponible en: https://iwgdfguidelines.org/pad-guideline/. Consulta: octubre de 2020.
VII. Gibbons G, Shaw P. Diabetic vascular disease: Characteristics of vascular disease unique to the diabetic patient. Semin Vasc Surg 2012; 25:89-92.
VIII. Pedrosa H, Campillo N, Braver J, Antonucci R, Jubiz Y, Barragan D. Consenso pie diabético ALAD-GEPLED. Revista de la Sociedad Argentina de Diabetes 2013;47: 93-114.
IX. Singh N, Armstrong DG, Lipsky BA. Preventing foot ulcers in patients with diabetes. JAMA 2005; 293:217-228.
X. Bus S, Lavery L, Monteiro-Soares M, Rasmussen A, Raspovic A, Sacco I, et al. IWGDF guidelines on the prevention and management of diabetic foot disease 2019. Disponible en: https://iwgdfguidelines.org/wp-content/uploads/2019/05/02-IWGDF-prevention-guideline-2019.pdf. Consulta: octubre de 2020.
XI. Ibrahim A, Jude E, Langton K, et al. IDF clinical practice recommendations on the diabetic foot 2017. Disponible en: https://www.idf.org/about-diabetes/54-our-activities/222-idf-clinical-practice-recommendations-on-the-diabetic-foot.html. Consulta: octubre de 2020.
XII. Takahashi O, Sakakibara R, Tateno F, Aiba Y. Diabetic neuropathy: distribution pattern revisited. Case Rep Neurol 2020; 12:160-164.
XIII. Domínguez C, Flores C, Fuente G, et al. Actualización del tratamiento de la polineuropatía diabética periférica dolorosa 2015. Comité de Neuropatía Diabética. Sociedad Argentina de Diabetes. Revista de la Sociedad Argentina de Diabetes 2016; 50:35-46.
XIV. Moss SE, et al. The prevalence and incidence of lower extremity amputation in a diabetic population WESDR. Arch Intern Med 1992; 152:610-616.
XV. Carro G, Saurral R, Salvador F, et al. Pie diabético en pacientes internados en Hospitales de Latinoamérica. Medicina (Buenos Aires) 2018; 78:243-251.
XVI. Miller J, Carter E, Shih J, et al. How to do a 3-minute diabetic foot exam. The Journal of Family Practice 2014; 63:646-656.
XVII. Dorresteijn J, Kriegsman D, Assendelft W, et al. Patient education for preventing diabetic foot ulceration. Cochrane Database Syst Rev 2014; (12):CD001488.
XVIII. Sharma S, Kerry C, Atkins H, et al. The Ipswich touch test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med 2014; 31(9):1100-1103.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 on behalf of the authors. Reproduction rights: Argentine Diabetes Society
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Dirección Nacional de Derecho de Autor, Exp. N° 5.333.129. Instituto Nacional de la Propiedad Industrial, Marca «Revista de la Sociedad Argentina de Diabetes - Asociación Civil» N° de concesión 2.605.405 y N° de disposición 1.404/13.
La Revista de la SAD está licenciada bajo Licencia Creative Commons Atribución – No Comercial – Sin Obra Derivada 4.0 Internacional.
Por otra parte, la Revista SAD permite que los autores mantengan los derechos de autor sin restricciones.
